Annotation Detail for FAM13A

Basic Information
Top
Pathway ID | Pathway Name |
---|
| Signaling by Rho GTPases |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of FAM13A mRNA | affects expression | 17562736
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of FAM13A mRNA | increases expression | 19270015
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
4.32 | 6195326 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
4.86 | 17620307 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.91 | 10982225 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.39 | 18445737 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
3.04 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
3.04 | 1701930 17173139 20007298 20935162 6705139 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.83 | 10977129 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
5.02 | 4080065 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
1.68 | 16393943 11461765 10663392 10915739 11743745 19416960 19420014 11287661 11739529 11421492 18713872 15968718 19164858 11834606 16485898 18071297 12594235 17906064 11529661 12540782 19370779 16177239 19923254 12958197 2444490 14725611 14550746 19739265 17562736 19085960 16081117 14986274 10774834 16227642 12392966 12153990 16109766 16781746 15619225 17522070 12705907 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
5.17 | 19426721 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
4.61 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
4.87 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
4.94 | 3922381 11558140 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
3.10 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
4.01 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
5.02 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
4.90 | 3659116 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
4.74 | 16983495 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
4.25 | 16109766 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
3.11 | 16870215 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.44 | 12587719 15629191 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
3.12 | 21047994 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
4.25 | 16610002 12969438 16611625 19460945 11587558 19014921 12587719 19784758 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
4.25 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.74 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
2.45 | 19073162 19812893 8742319 15975961 21047994 19482888 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
2.97 | 6150874 1399818 2563599 17172636 18308698 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
4.33 | 19513568 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
5.36 | 17484760 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.31 | 18514411 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
5.25 | 17016548 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.82 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
2.62 | 16965848 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
4.09 | 2563599 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
5.56 | 12752131 |
MESH:D029424 |
Pulmonary Disease, Chronic Obstructive |
marker/mechanism |
|
| 20173748 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
3.01 | 16876388 3137016 11442880 4039156 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
5.71 | 6407741 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
3.43 | 1399818 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.58 | 10982225 |
Pathway ID |
Pathway Name |
---|
REACT:11044 |
Signaling by Rho GTPases |